Genscreen is a privately held biotechnology company dedicated to making a difference through the application of advances in scientific and medical research and biotechnology to address unmet medical and research needs.
We are based in Melbourne, Australia and have established relationships across some of the main research and medical centres in Australia and now across the world, with links to USA, China and United Kingdom.
Our present portfolio of assets include:
- our shareholding in Cell Therapies Pty Ltd
- 3 anticancer small molecule programs in Trobio Pty Ltd (82% owned by us)
- 100% ownership of RESET program
Our team covers the range of skills and experience required in this arena.
Our focus is on bringing therapeutics, diagnostics and medical devices to commercial reality - often through joint venture of partnerships.
We have a very hands-on approach to our operations and run the operations in a cost-effective and commercially focussed manner.
Genscreen works with selected people and organisations to:
- identify projects and IP with particular merit, and
- build sustainable and valuable businesses based on significant Australian scientific and medical research innovation and discovery
We have a very international focus to all aspect of our operations. The Genscreen team is experienced in building businesses that link advanced technology, services or IP with international market needs and partners.
Our special areas of interest include:
- health and research service businesses
- drug discovery and drug development businesses
- medical devices businesses and technology
Click on Genscreen Portfolio to view our present portfolio of businesses and projects.
Genscreen uses international biotech and research partnerships to achieve its “route to market” objectives.